Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (1023)	6/10/2003 3:37:52 PM
From: Jibacoa	Read Replies (3) \| Respond to of 7424

PGLAF Is up 41.5% with volume over 900K No new "news" since June 4, when they discussed the advantages of their Progen's PI-88, which "rather than relying on a single mode of action to induce an anticancer response, its anti-angiogenic properties derive from inhibiting multiple growth factors, including FGFs and VEGF, as well as inhibiting other angiogenic agents, including heparanase." biz.yahoo.com siliconinvestor.com Bernard

To: Icebrg who wrote (1023)	6/10/2003 5:27:12 PM
From: dalroi	Respond to of 7424

Erik let it be what it want i was a very very nice ride Thanks !!!! Stefaan next please ...............